Headline
- ‘Tagor’ motion poster revealed; Ador and Puja cast as leads
- UK to announce new sanctions against Russia on February 24: Report
- Oscar favorite 'Anora' wins best film, director, and actor at the Independent Spirit Awards
- Is spending all day on your feet at work an occupational hazard?
- Barcelona claim narrow win at Las Palmas to reclaim Liga lead
- Trump says US wants return on Ukraine aid money
- Economic stagnation continues
- Prothom Alo and The Daily Star: The masterminds of Begum Zia’s minus conspiracy
- Mexican migrant shelters empty despite Trump's deportation threat
- Guirassy scores 4 goals for Dortmund, first to do so since Haaland
- Cholera kills 58 over 3 days in a Sudanese city
- Messi assists on Segovia’s late goal, Inter Miami draws with NYCFC
- DCCI urges govt to boost private sector growth and tackle inflation
- Arsenal title bid rocked by West Ham
- Dhaka's air still 'unhealthy' today
- Protesters extend 'Dark Indonesia' rally against Prabowo's policies
- Abu Sayeed dispels fear from hearts of Bengalese with life: Mahmudur Rahman
- Cook Islands announces deep sea minerals deal with China
- Bangladesh also walks out during Israeli speech at Global Ministerial Conference
- Early wicket loss against India an accident: Razzak

WHO announces new guidelines for HIV testing protocols
The World Health Organization (WHO) is convening a Guideline Development Group (GDG) to create new guidelines for the use of injectable lenacapavir as pre-exposure prophylaxis (PrEP) for HIV, along with updated recommendations for optimizing HIV testing services for long-acting prevention products....

A twice-yearly shot could help end AIDS
A new HIV prevention shot, hailed as a major breakthrough in the fight against AIDS, has demonstrated near-perfect results in clinical trials. The drug, known as Lenacapavir, requires administration only twice a year. A study showed it was 100% effective in preventing HIV infections among women and...